Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.03−0.51 (-20.08%)
Close on Nov 19, 2026Market cap $16.93MP/E –Yield –
Evaxion A/S gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Evaxion A/S
Evaxion A/S has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?